Colin Muething
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Colin Muething has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Nathan A. Call
Marcus Autism Center, Children’s Healthcare of Atlanta, Atlanta, USA
2 shared publications Alexis Pavlov
Children's Healthcare of Atlanta, Marcus Autism Center, Atlanta, GA
1 shared publication- Carolyn M. Ritchey
Georgia Southern University Savannah Georgia USA
1 shared publication - Chelsea R. Fleck
Marcus Autism Center Atlanta GA USA
1 shared publication - Christopher A. Podlesnik
Department of Psychology University of Florida Gainesville FL USA
1 shared publication - Courtney Hannula
Division of Autism and Related Disorders, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
1 shared publication
Latest Publications
- 30 June 2026
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
Intensive Outpatient Treatment for Patients With Severe Externalizing Behavior and Intellectual and Developmental Disability: An Electronic Health Record Review
Objective: Evaluate the outcomes of individuals with intellectual and developmental disabilities (IDD) admitted to an intensive behavior treatment program to reduce severe externalizing behavior (e.g., aggression; self-injury). Methods: The authors conducted a retrospective electronic health record review of 40 consecutive patients aged 6 to 19 years with severe externalizing behavior causing imminent risk of harm to self or others over a 4-year period (January 2020 to December 2023). The intensive outpatient model involved daily intervention (Monday–Friday; 5 hours per day across an approximate 5-month period) that was structured and individualized based on the tenants of applied behavior analysis. Systematic data extraction included participant characteristics, outcomes of behavioral assessments, components of the behavioral intervention, percent reduction of externalizing behavior, and percent of caregiver-directed goals met. Results: All participants had a diagnosis of autism and 80% had a co-occurring intellectual disability. Participants presented with 3 primary types of externalizing behavior—aggression (87.5%), disruption (82.5%), and self-injury (67.5%). At discharge, participants had a 90.74% reduction in externalizing behavior and 82.5% of participants met their primary caregiver-directed goal. Conclusion: Findings provide provisional evidence regarding the benefits of intensive behavioral treatment for children with IDD and severe externalizing behavior.
- 30 June 2026
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
Intensive Outpatient Treatment for Patients With Severe Externalizing Behavior and Intellectual and Developmental Disability: An Electronic Health Record Review
Objective: Evaluate the outcomes of individuals with intellectual and developmental disabilities (IDD) admitted to an intensive behavior treatment program to reduce severe externalizing behavior (e.g., aggression; self-injury). Methods: The authors conducted a retrospective electronic health record review of 40 consecutive patients aged 6 to 19 years with severe externalizing behavior causing imminent risk of harm to self or others over a 4-year period (January 2020 to December 2023). The intensive outpatient model involved daily intervention (Monday–Friday; 5 hours per day across an approximate 5-month period) that was structured and individualized based on the tenants of applied behavior analysis. Systematic data extraction included participant characteristics, outcomes of behavioral assessments, components of the behavioral intervention, percent reduction of externalizing behavior, and percent of caregiver-directed goals met. Results: All participants had a diagnosis of autism and 80% had a co-occurring intellectual disability. Participants presented with 3 primary types of externalizing behavior—aggression (87.5%), disruption (82.5%), and self-injury (67.5%). At discharge, participants had a 90.74% reduction in externalizing behavior and 82.5% of participants met their primary caregiver-directed goal. Conclusion: Findings provide provisional evidence regarding the benefits of intensive behavioral treatment for children with IDD and severe externalizing behavior.
- 12 December 2024
- Published by Wiley in Journal of Applied Behavior Analysis
- Vol. 58 (1) , 225-231
Different criteria affect prevalence of relapse of behavior targeted for treatment
Several studies have examined the prevalence of behavioral relapse among individuals with intellectual and developmental disabilities following common treatment challenges (context changes, schedule thinning). Most applied studies compare behavior during the treatment challenges with the maximum level of behavior from five preceding treatment sessions. This max‐of‐5 criterion could inadvertently capture behavior in transition during the preceding treatment phase, thereby underestimating the prevalence of relapse. In the current study, we reanalyzed existing clinical data with the max‐of‐5 criterion and an alternative criterion less likely to capture target behavior in transition—the mean of the last two sessions (mean‐of‐2 criterion) of the treatment phase. As hypothesized, the max‐of‐5 criterion produced lower prevalence estimates relative to the mean‐of‐2 criterion. We encourage researchers conducting these analyses to weigh different approaches to reporting prevalence data and discuss considerations for future areas of research and practice related to measurement of relapse.
- 12 December 2024
- Published by Wiley in Journal of Applied Behavior Analysis
- Vol. 58 (1) , 225-231
Different criteria affect prevalence of relapse of behavior targeted for treatment
Several studies have examined the prevalence of behavioral relapse among individuals with intellectual and developmental disabilities following common treatment challenges (context changes, schedule thinning). Most applied studies compare behavior during the treatment challenges with the maximum level of behavior from five preceding treatment sessions. This max‐of‐5 criterion could inadvertently capture behavior in transition during the preceding treatment phase, thereby underestimating the prevalence of relapse. In the current study, we reanalyzed existing clinical data with the max‐of‐5 criterion and an alternative criterion less likely to capture target behavior in transition—the mean of the last two sessions (mean‐of‐2 criterion) of the treatment phase. As hypothesized, the max‐of‐5 criterion produced lower prevalence estimates relative to the mean‐of‐2 criterion. We encourage researchers conducting these analyses to weigh different approaches to reporting prevalence data and discuss considerations for future areas of research and practice related to measurement of relapse.